• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

竞争性干预措施的间接比较

Indirect comparisons of competing interventions.

作者信息

Glenny A M, Altman D G, Song F, Sakarovitch C, Deeks J J, D'Amico R, Bradburn M, Eastwood A J

机构信息

Cochrane Oral Health Group, Dental School, University of Manchester, UK.

出版信息

Health Technol Assess. 2005 Jul;9(26):1-134, iii-iv. doi: 10.3310/hta9260.

DOI:10.3310/hta9260
PMID:16014203
Abstract

OBJECTIVES

To survey the frequency of use of indirect comparisons in systematic reviews and evaluate the methods used in their analysis and interpretation. Also to identify alternative statistical approaches for the analysis of indirect comparisons, to assess the properties of different statistical methods used for performing indirect comparisons and to compare direct and indirect estimates of the same effects within reviews.

DATA SOURCES

Electronic databases.

REVIEW METHODS

The Database of Abstracts of Reviews of Effects (DARE) was searched for systematic reviews involving meta-analysis of randomised controlled trials (RCTs) that reported both direct and indirect comparisons, or indirect comparisons alone. A systematic review of MEDLINE and other databases was carried out to identify published methods for analysing indirect comparisons. Study designs were created using data from the International Stroke Trial. Random samples of patients receiving aspirin, heparin or placebo in 16 centres were used to create meta-analyses, with half of the trials comparing aspirin and placebo and half heparin and placebo. Methods for indirect comparisons were used to estimate the contrast between aspirin and heparin. The whole process was repeated 1000 times and the results were compared with direct comparisons and also theoretical results. Further detailed case studies comparing the results from both direct and indirect comparisons of the same effects were undertaken.

RESULTS

Of the reviews identified through DARE, 31/327 (9.5%) included indirect comparisons. A further five reviews including indirect comparisons were identified through electronic searching. Few reviews carried out a formal analysis and some based analysis on the naive addition of data from the treatment arms of interest. Few methodological papers were identified. Some valid approaches for aggregate data that could be applied using standard software were found: the adjusted indirect comparison, meta-regression and, for binary data only, multiple logistic regression (fixed effect models only). Simulation studies showed that the naive method is liable to bias and also produces over-precise answers. Several methods provide correct answers if strong but unverifiable assumptions are fulfilled. Four times as many similarly sized trials are needed for the indirect approach to have the same power as directly randomised comparisons. Detailed case studies comparing direct and indirect comparisons of the same effect show considerable statistical discrepancies, but the direction of such discrepancy is unpredictable.

CONCLUSIONS

Direct evidence from good-quality RCTs should be used wherever possible. Without this evidence, it may be necessary to look for indirect comparisons from RCTs. However, the results may be susceptible to bias. When making indirect comparisons within a systematic review, an adjusted indirect comparison method should ideally be used employing the random effects model. If both direct and indirect comparisons are possible within a review, it is recommended that these be done separately before considering whether to pool data. There is a need to evaluate methods for the analysis of indirect comparisons for continuous data and for empirical research into how different methods of indirect comparison perform in cases where there is a large treatment effect. Further study is needed into when it is appropriate to look at indirect comparisons and when to combine both direct and indirect comparisons. Research into how evidence from indirect comparisons compares to that from non-randomised studies may also be warranted. Investigations using individual patient data from a meta-analysis of several RCTs using different protocols and an evaluation of the impact of choosing different binary effect measures for the inverse variance method would also be useful.

摘要

目的

调查系统评价中间接比较的使用频率,并评估其分析和解释中所采用的方法。同时识别用于间接比较分析的替代统计方法,评估用于进行间接比较的不同统计方法的特性,并在系统评价中比较同一效应的直接和间接估计值。

数据来源

电子数据库。

综述方法

检索效果综述文摘数据库(DARE),查找涉及随机对照试验(RCT)荟萃分析的系统评价,这些评价报告了直接和间接比较,或仅报告了间接比较。对MEDLINE和其他数据库进行系统综述,以识别已发表的分析间接比较的方法。利用国际卒中试验的数据创建研究设计。在16个中心,使用接受阿司匹林、肝素或安慰剂治疗的患者随机样本进行荟萃分析,其中一半试验比较阿司匹林和安慰剂,另一半比较肝素和安慰剂。使用间接比较方法估计阿司匹林和肝素之间的对比。整个过程重复1000次,并将结果与直接比较结果以及理论结果进行比较。开展了更详细的案例研究,比较同一效应的直接和间接比较结果。

结果

通过DARE识别的综述中,31/327(9.5%)包含间接比较。通过电子检索又识别出另外5篇包含间接比较的综述。很少有综述进行正式分析,一些分析基于对感兴趣治疗组数据的简单相加。识别出的方法学论文很少。发现了一些可使用标准软件应用于汇总数据的有效方法:调整后的间接比较、荟萃回归,对于二元数据,仅为多重逻辑回归(仅固定效应模型)。模拟研究表明,简单方法容易产生偏差,并且给出的答案过于精确。如果满足强但不可验证假设,几种方法可提供正确答案。间接方法要具有与直接随机比较相同的检验效能,所需样本量是直接方法的四倍。比较同一效应直接和间接比较的详细案例研究显示出相当大的统计差异,但这种差异的方向不可预测。

结论

应尽可能使用高质量RCT的直接证据。没有此证据时,可能有必要从RCT中寻找间接比较。然而,结果可能容易产生偏差。在系统评价中进行间接比较时,理想情况下应使用采用随机效应模型的调整间接比较方法。如果在一个综述中既可以进行直接比较也可以进行间接比较,建议在考虑合并数据之前分别进行。需要评估连续数据间接比较分析方法,以及在存在较大治疗效应情况下不同间接比较方法性能的实证研究。需要进一步研究何时适合查看间接比较,以及何时同时结合直接和间接比较。也可能有必要研究间接比较证据与非随机研究证据的比较情况。使用来自几个采用不同方案的RCT荟萃分析的个体患者数据进行调查,以及评估为逆方差法选择不同二元效应测量指标的影响也会很有用。

相似文献

1
Indirect comparisons of competing interventions.竞争性干预措施的间接比较
Health Technol Assess. 2005 Jul;9(26):1-134, iii-iv. doi: 10.3310/hta9260.
2
A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.一项对随机研究和非随机研究得出的效应量比较的系统综述。
Health Technol Assess. 2000;4(34):1-154.
3
Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses.间接比较在评估竞争性干预措施疗效方面的有效性:来自已发表的荟萃分析的实证证据。
BMJ. 2003 Mar 1;326(7387):472. doi: 10.1136/bmj.326.7387.472.
4
Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.回复拉赫曼·希里博士的来信:职业群体中的自杀这一具有挑战性的话题。
Scand J Work Environ Health. 2018 Jan 1;44(1):108-110. doi: 10.5271/sjweh.3698. Epub 2017 Dec 8.
5
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies.在快速发展技术的卫生技术评估中,会议摘要和报告与全文文章的比较。
Health Technol Assess. 2006 Feb;10(5):iii-iv, ix-145. doi: 10.3310/hta10050.
6
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Indirect comparisons of treatments based on systematic reviews of randomised controlled trials.基于随机对照试验系统评价的治疗方法间接比较。
Int J Clin Pract. 2009 Jun;63(6):841-54. doi: 10.1111/j.1742-1241.2009.02072.x.
9
Randomised controlled trials for policy interventions: a review of reviews and meta-regression.随机对照试验对政策干预的影响:综述和元回归分析。
Health Technol Assess. 2010 Mar;14(16):1-165, iii. doi: 10.3310/hta14160.
10
Indirect comparisons: a review of reporting and methodological quality.间接比较:报告和方法学质量评价。
PLoS One. 2010 Nov 10;5(11):e11054. doi: 10.1371/journal.pone.0011054.

引用本文的文献

1
Evidence on antidepressant withdrawal: an appraisal and reanalysis of a recent systematic review.抗抑郁药撤药的证据:对近期一项系统评价的评估与重新分析
Psychol Med. 2025 Jul 22;55:e191. doi: 10.1017/S0033291725100652.
2
Selection of indirect treatment comparisons for health technology assessments: a practical guide for health economics and outcomes research scientists and clinicians.卫生技术评估中间接治疗比较的选择:卫生经济学与结果研究科学家及临床医生实用指南
BMJ Open. 2025 Mar 25;15(3):e091961. doi: 10.1136/bmjopen-2024-091961.
3
Risk of Bias in Network Meta-Analysis (RoB NMA) tool.
网状Meta分析中的偏倚风险(RoB NMA)工具
BMJ. 2025 Mar 18;388:e079839. doi: 10.1136/bmj-2024-079839.
4
Adjuvant endocrine treatment strategies for non-metastatic breast cancer: a network meta-analysis.非转移性乳腺癌的辅助内分泌治疗策略:一项网状荟萃分析。
EClinicalMedicine. 2025 Feb 17;81:103116. doi: 10.1016/j.eclinm.2025.103116. eCollection 2025 Mar.
5
Effectiveness of pharmacological therapies for fibromyalgia syndrome in adults: an overview of Cochrane Reviews.成人纤维肌痛综合征药物治疗的有效性:Cochrane系统评价概述
Rheumatology (Oxford). 2025 May 1;64(5):2385-2394. doi: 10.1093/rheumatology/keae707.
6
Comparative effectiveness of treatments for recurrent infection: a network meta-analysis of randomized controlled trials.复发性感染治疗的比较效果:随机对照试验的网状Meta分析
Front Pharmacol. 2024 Oct 17;15:1430724. doi: 10.3389/fphar.2024.1430724. eCollection 2024.
7
Matching-Adjusted Indirect Comparison of Risankizumab Versus Deucravacitinib in Patients with Moderate-to-Severe Plaque Psoriasis.中度至重度斑块状银屑病患者中瑞莎珠单抗与德卡伐替尼的匹配调整间接比较
Dermatol Ther (Heidelb). 2024 Nov;14(11):3071-3081. doi: 10.1007/s13555-024-01293-y. Epub 2024 Oct 25.
8
Exercise-Based Interventions Are Effective in the Management of Patients with Thumb Carpometacarpal Osteoarthritis: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.基于运动的干预措施对拇指腕掌关节骨关节炎患者的管理有效:一项随机对照试验的系统评价和荟萃分析
Healthcare (Basel). 2024 Apr 12;12(8):823. doi: 10.3390/healthcare12080823.
9
Methods for Indirect Treatment Comparison: Results from a Systematic Literature Review.间接治疗比较方法:系统文献综述结果
J Mark Access Health Policy. 2024 Apr 16;12(2):58-80. doi: 10.3390/jmahp12020006. eCollection 2024 Jun.
10
Low awareness of the transitivity assumption in complex networks of interventions: a systematic survey from 721 network meta-analyses.干预复杂网络中转导性假设的意识水平较低:来自 721 项网络荟萃分析的系统调查。
BMC Med. 2024 Mar 13;22(1):112. doi: 10.1186/s12916-024-03322-1.